Context Therapeutics to Participate in Two April 2023 Investor Conferences

(marketscreener.com) PHILADELPHIA, April 03, 2023 -- Context Therapeutics Inc. , a biopharmaceutical company developing novel treatments for solid tumors, today announced that Chief Executive Officer Martin Lehr will participate virtually in two investor conferences in April 2023. Details of the events are as follows: Diamond Equity Emerging Growth Invitational...https://www.marketscreener.com/quote/stock/CONTEXT-THERAPEUTICS-INC-125228671/news/Context-Therapeutics-to-Participate-in-Two-April-2023-Investor-Conferences-43414166/?utm_medium=RSS&utm_content=20230403